B.S., Microbiology, University of California, Los Angeles, Los Angeles, Calif., 1998.
B.S., Molecular Genetics, University of California, Los Angeles, Los Angeles, Calif., 1998.
M.S., Chemistry, Purdue University, West Lafayette, Ind., 2003.
Pharm.D., Creighton University, Omaha, Neb., 2006.
M.B.A., University of Michigan, Ann Arbor, Mich., 2014.

Eli Lilly and Company, Indianapolis, Ind., biochemist/senior biochemist/regulatory scientist, 1999-2005; Creighton University School of Pharmacy and Health Professions, Omaha, Neb., adjunct faculty, 2006-2008; St. Francis Hospital and Health Centers, Indianapolis, Ind., clinical research pharmacist, 2007-2012; Eli Lilly and Company, Indianapolis, Ind., global launch optimization leaders, 2006-2008; global alliance and portfolio management, 2008-2012; Upsher-Smith, Maple Grove, Minn., strategic opportunities management, 2012-2013; senior director, Corporate Development, 2013-2016; vice president, Portfolio Strategy, 2016-2017; vice president, Corporate Development, 2017-2019.

Joined the staff of Mayo Clinic, 2020; Business Development, vice chair, Corporate Development, 2020-2022; chair, 2022-present.